STING1 and melanoma: Although T cell activation occurs mainly in TDLNs, STING signaling has been reported to induce the formation of intra-tumor tertiary lymphoid structures (TLS) in a mouse model of melanoma (33), where DCs may activate T cells, thereby skipping the need for migration to TDLNs (34).